4. Genetic analysis of acute lymphoblastic leukemia developed after treatment with lenalidomide for multiple myeloma

      Introduction: Patients with multiple myeloma (MM) who are treated with lenalidomide maintenance therapy can be subsequently diagnosed with acute lymphoblastic leukemia (ALL). To describe the clonal dynamics of this transformation, we performed somatic and germline sequence analysis of six patients who developed Philadelphia chromosome-negative (Ph-negative) ALL after a primary diagnosis of MM while on/or after maintenance therapy with lenalidomide.
      To read this article in full you will need to make a payment


      Subscribe to Cancer Genetics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect